Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private Placement
July 17, 2026
July 17, 2026
CHICAGO, Illinois, July 17 [Category: BizLaw/Legal] -- Sidley Austin, a law firm, posted the following news release:
* * *
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private Placement
*
Sidley represented NextCure, Inc. (Nasdaq: NXTC) in its definitive merger agreement with Avere Therapeutics, Inc. in an all-stock transaction. Upon closing, which is expected to occur in the second half of 2026, th . . .
* * *
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private Placement
*
Sidley represented NextCure, Inc. (Nasdaq: NXTC) in its definitive merger agreement with Avere Therapeutics, Inc. in an all-stock transaction. Upon closing, which is expected to occur in the second half of 2026, th . . .